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Background
Recent observational studies suggest that bleeding from 
stress ulceration is extremely uncommon in intensive 
care unit patients. Furthermore, the risk of bleeding may 
not be altered by the use of acid suppressive therapy. 
Early enteral tube feeding (initiated within 48 h of inten-
sive care unit admission) may account for this obser-
vation. Stress ulcer prophylaxis may, however, increase 
the risk of hospital-acquired pneumonia and Clostridia 
diﬃ  cile infection.
Methods
Objective: A systematic review of the literature to deter-
mine the beneﬁ t and risks of stress ulcer prophylaxis and 
the moderating eﬀ ect of enteral nutrition.
Design: 
Data Sources: MEDLINE, Embase, Cochrane Register of 
Controlled Trials, and citation review of rele vant primary 
and review articles.
Study Selection: Randomized, controlled studies that 
evaluated the asso ciation between stress ulcer prophy-
laxis and gastro intestinal bleeding. Th e authors included 
only those studies that compared a histamine-2 receptor 
blocker with a placebo.
Data Extraction: Data were abstracted on study design, 
study size, study setting, patient population, histamine-2 
receptor blocker and dosage used, incidence of clinically 
signiﬁ cant gastrointestinal bleeding, hospital-acquired 
pneumonia, mortality, and the use of enteral nutrition.
Results
Seventeen studies (which enrolled 1836 patients) met the 
inclusion criteria. Patients received adequate enteral 
nutrition in three of the studies. Overall, stress ulcer 
prophylaxis with a histamine-2 receptor blocker reduced 
the risk of gastrointestinal bleeding (odds ratio 0.47; 95% 
conﬁ dence interval, 0.29–0.76; P <  0.002; Heterogeneity 
[I2] = 44%); however, the treatment eﬀ ect was noted only 
in the subgroup of patients who did not receive enteral 
nutrition. In those patients who were fed enterally, stress 
ulcer prophylaxis did not alter the risk of gastrointestinal 
bleeding (odds ratio 1.26; 95% conﬁ dence interval, 0.43–
3.7). Overall histamine-2 receptor blockers did not 
increase the risk of hospital-acquired pneumonia (odds 
ratio 1.53; 95% conﬁ dence interval, 0.89 –2.61; P = 0.12; 
I2  =  41%); however, this complication was increased in 
the subgroup of patients who were fed enterally (odds 
ratio 2.81; 95% conﬁ dence interval, 1.20–6.56; P  =  0.02; 
I2 = 0%). Overall, stress ulcer prophylaxis had no eﬀ ect on 
hospital mortality (odds ratio 1.03; 95% conﬁ dence 
interval, 0.78–1.37; P = 0.82). Th e hospital mortality was, 
however, higher in those studies (n = 2) in which patients 
were fed enterally and received a histamine-2 receptor 
blocker (odds ratio 1.89; 95% conﬁ dence interval, 1.04–
3.44; P  =  0.04, I2  =  0%). Sensitivity analysis and meta-
regression demonstrated no relationship between the 
treatment eﬀ ect (risk of gastrointestinal bleeding) and 
the classiﬁ cation used to deﬁ ne gastrointestinal bleeding, 
the Jadad quality score or the year the study was reported.
Conclusions
Th e results of this meta-analysis suggest that, in those 
patients receiving enteral nutrition, stress ulcer prophy-
laxis may not be required and, indeed, such therapy may 
increase the risk of pneumonia and death. However, 
because no clinical study has prospectively tested the 
inﬂ uence of enteral nutrition on the risk of stress ulcer 
prophylaxis, those ﬁ ndings should be considered explora-
tory and interpreted with some caution.© 2010 BioMed Central Ltd
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Commentary
In 1969, Skillman et al. [1] reported a clinical syndrome 
of lethal “stress ulceration” in seven of 150 (5%) 
consecutive intensive care unit (ICU) patients. Th ese 
patients had in common respiratory failure, hypotension, 
and sepsis. Subsequent studies conﬁ rmed this ﬁ nding 
and two meta-analyses published by Cook et al. [2] 
demonstrated that both histamine-2 receptor blockers 
(H2RBs) and sucralfate decreased the risk of bleeding 
from stress ulceration when compared to a placebo. 
Stress ulcer prophylaxis (SUP) becomes regarded as the 
standard of care in patients admitted to the intensive 
Care Unit (ICU), and this intervention is currently 
endorsed by Surviving sepsis campaign and American 
Society of Health System Pharmacists (ASHP) guidelines. 
Th e universal use of SUP has been reinforced with the 
adoption of “ventilator bundles.” Currently Joint Com-
mission and the Institute for Healthcare Improvement 
recommend universal SUP as a core “quality” measure for 
mechanically ventilated patients.
Although the Agency for Healthcare Research and 
Quality recommends using SUP only in patients on 
mechanical ventilation and high bleeding risk from 
coagulopathies, SUP is used in all critically ill patients 
and even outside the ICU setting. For example, estimates 
indicate that approximately 90% of critically ill patients 
admitted to the ICU receive some form of SUP [3], and 
up to 52% of non-ICU patients receive SUP [4,5]. SUP is 
not without risks. Acid suppressive therapy is associated 
with increased colonization of the upper gastrointestinal 
tract with potentially pathogenic organisms and may 
increase the risk of hospital-acquired pneumonia [5]. 
Furthermore, gastric acid is an important defense against 
the acquisition of Clostridium diﬃ  cile spores, and the use 
of acid suppressive therapy has been linked to an 
increased risk of Clostridium diﬃ  cile infection [6-8]. 
Th us, understanding risks and beneﬁ ts of SUP is impor-
tant. For example, patients receiving enteral alimentation 
have a lower incidence of stress ulceration than unfed 
patients [9]. Whether routine SUP in patients who receive 
enteral feeding is beneﬁ cial or harmful is not known.
Marik et al. [10] conducted a meta-analysis of 17 
randomized clinical trials and postulated that SUP may 
have no added beneﬁ ts in ICU patients who receive 
enteral nutrition. Th ey examined the eﬀ ect of diﬀ erent 
SUP regimes on the risk of gastrointestinal bleeding, 
hospital-acquired pneumonia, and mortality, stratifying 
the studies based on enteral nutrition.
Th e meta-analysis included a total of 1836 enrolled 
between the years 1980 and 2004. Overall, SUP with a 
H2RB reduced the risk of GI bleeding (P < 0.002) but had 
no eﬀ ect on mortality. Th e beneﬁ cial eﬀ ect of SUP was 
noted only in the subgroup of patients who did not 
receive enteral nutrition. SUP did not alter the risk of GI 
bleeding in patients who received enteral nutrition, and 
these individuals had higher risk of hospital-acquired 
pneumonia (P  =  0.02, n  =  9 studies) and mortality 
(P = 0.04, n = 2 studies).
Th e results of this meta-analysis suggest that SUP may 
not be beneﬁ cial in patients who are fed enterally. Th e 
strength of this review article includes the rigorous 
attempt to identify all relevant RCTs studies, consider 
and evaluate for possible confounding factors, such as 
year of publications, deﬁ nition of gastrointestinal 
bleeding, quality of randomized controlled trials, and 
publication bias. Limitations of this article includes lack 
of homogeneity in patient population, diﬀ erence in 
diagnostic criteria used for major end-points, and only 
three studies had patients with enteral nutrition.
Recommendation
SUP is beneﬁ cial in high risk patients, including those 
that are on mechanical ventilation and have coagulopathy. 
SUP may cause unfavorable outcomes, such as hospital-
acquired pneumonia and Clostridium diﬃ  cile infection, 
and clinicians must weigh risks and beneﬁ ts in low-risk 
patients, such as those who are not requiring mechanical 
ventilation or are receiving enteral nutrition.
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